Surgalign Holdings, Inc.
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -11.04% | -9.42% | -12.25% | -18.23% | -10.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.04% | -9.42% | -12.25% | -18.23% | -10.34% |
| Cost of Revenue | -7.13% | -5.58% | 1.11% | 1.55% | -2.13% |
| Gross Profit | -12.87% | -11.11% | -17.09% | -25.12% | -13.73% |
| SG&A Expenses | -11.50% | -8.21% | -7.67% | -4.30% | -8.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 77.16% | 77.16% | -- | -- | -- |
| Total Operating Expenses | -8.49% | -3.69% | -3.95% | -1.54% | -6.27% |
| Operating Income | 4.44% | -6.35% | -12.33% | -39.48% | -0.99% |
| Income Before Tax | 52.54% | 55.05% | 32.26% | 39.17% | 41.20% |
| Income Tax Expenses | -13.68% | -17.72% | 141.08% | -404.58% | -446.69% |
| Earnings from Continuing Operations | 53.12% | 55.57% | 31.55% | 39.82% | 41.80% |
| Earnings from Discontinued Operations | -- | -- | -88.04% | -98.82% | -102.37% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.29% | 35.49% | 56.32% | -574.32% | -123.18% |
| EBIT | 4.44% | -6.35% | -12.33% | -39.48% | -0.99% |
| EBITDA | 3.89% | -7.27% | -19.69% | -54.03% | -11.36% |
| EPS Basic | 52.04% | 60.46% | 75.24% | -516.30% | -81.47% |
| Normalized Basic EPS | -165.20% | -202.85% | 117.67% | 117.40% | 112.88% |
| EPS Diluted | 48.59% | 60.45% | 75.23% | -518.33% | -81.25% |
| Normalized Diluted EPS | -159.87% | -202.19% | 117.74% | 117.47% | 112.94% |
| Average Basic Shares Outstanding | 50.41% | 58.79% | 66.01% | 78.17% | 74.81% |
| Average Diluted Shares Outstanding | 76.70% | 59.87% | 67.25% | 79.63% | 76.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |